Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
Cleveland Clinic Lerner, Cleveland, OH, United States
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Neural Habituation Explains Memory Dysfunction in the Early Stage of Schizophrenia
A Family-Focused, Literacy-Sensitive Intervention to Improve Medication Adherence
Notch signaling-mediated functions of airway eosinophils in lung disease
Research Services
Software for genomic and methylation-specific MLPA probe design
Recently added grants:
TGF-? signaling and regulation: Elucidating molecular mechanisms and pathogenic functions of the ?co-receptor? Cripto-1 and the receptor BMPRII
Modeling Endothelial Dysfunction in LMNA-related Dilated Cardiomyopathy
CYP1 Inhibition as a New Therapeutic Strategy for Doxorubicin Cardiomyopathy
The role of energy sensor signaling in mitochondrial cardiomyopathy
Xavier RCMI Renewal Application-Overall
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025140-002
Application #
6828866
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Related projects
NIH 2003
N01 CA
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
/ Cleveland Clinic Lerner
NIH 2002
N01 CA
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
/ Cleveland Clinic Lerner
Comments
Be the first to comment on this grant